Publications of Note

Improvement in Facial Seborrheic Dermatitis Following Cervical Transcutaneous Vagal Nerve Stimulation

Full Post A case report published in JAAD Case Reports (July 2025) explores the potential benefits of cervical transcutaneous vagus nerve stimulation (tVNS) in treating seborrheic dermatitis, a chronic inflammatory skin condition. The report describes a 56-year-old man who began using a non-invasive vagus nerve stimulation device for headaches and subsequently experienced significant improvement in […]

Improvement in Facial Seborrheic Dermatitis Following Cervical Transcutaneous Vagal Nerve Stimulation Read More »

Transcutaneous Auricular Vagus Nerve Stimulation Improves Dysautonomia in Patients with Hypermobile Ehlers-Danlos Syndrome

Full Post A newly published study in Neurological Sciences examined the use of transcutaneous auricular vagus nerve stimulation (taVNS) in patients with hypermobile Ehlers-Danlos syndrome (hEDS) experiencing disabling dysautonomia. Dysautonomia is common in hEDS and can contribute to symptoms including orthostatic intolerance, gastrointestinal dysfunction, vasomotor instability, fatigue, and other multisystem complaints. The researchers investigated whether

Transcutaneous Auricular Vagus Nerve Stimulation Improves Dysautonomia in Patients with Hypermobile Ehlers-Danlos Syndrome Read More »

Vagus Nerve Stimulation and the Gut–Brain Axis in Neurodevelopmental Disorders

Full Post A recently published article in Frontiers in Neuroscience examines the potential of vagus nerve stimulation as an integrative add-on therapy for neurodevelopmental disorders such as autism spectrum disorder, attention-deficit/hyperactivity disorder, and epilepsy. The authors describe the microbiota–gut–brain axis as a bidirectional communication network connecting the gastrointestinal system and the brain through neural, immune,

Vagus Nerve Stimulation and the Gut–Brain Axis in Neurodevelopmental Disorders Read More »

Vagus Nerve Society Position Statement: WISeR Model and VNS for Epilepsy

Vagus Nerve Society Position Statement: WISeR Model and VNS for Epilepsy   The Centers for Medicare & Medicaid Innovation (CMMI) has announced the 6-year WISeR (Wasteful and Inappropriate Service Reduction) pilot, which applies AI-driven prior authorization to select “low-value” services in Medicare FFS. Beginning January 2026 in six states (Texas, New Jersey, Washington, Ohio, Arizona

Vagus Nerve Society Position Statement: WISeR Model and VNS for Epilepsy Read More »

whyus secbg

The cholinergic anti-inflammatory pathway in chronic kidneydisease—review and vagus nerve stimulation clinical pilot study

Marie Hilderman1 and Annette Bruchfeld1,2 ABSTRAC: TInflammation and autonomic dysfunction are common find-ings in chronic and end-stage kidney disease and contribute to amarkedly increased risk of mortality in this patient population.The cholinergic anti-inflammatory pathway (CAP) is a vagalneuro-immune circuit that upholds the homoeostatic balanceof inflammatory activity in response to cell injury and patho-gens. CAP models have been

The cholinergic anti-inflammatory pathway in chronic kidneydisease—review and vagus nerve stimulation clinical pilot study Read More »

whyus secbg

Noninvasive VNS Shown Effective For Symptoms of Vestibular Migraine

Noninvasive vagus nerve stimulation provided rapid relief of vertigo and headache pain caused by acute vestibular migraine (VM), the most common neurologic cause of vertigo, according to a study using retrospective chart review. The study of 18 patients (Neurology 2019;93[18]: e1715-e1719), conducted at a single tertiary referral center between November 2017 and January 2019, found

Noninvasive VNS Shown Effective For Symptoms of Vestibular Migraine Read More »

Become a Part of the Vagus Nerve Society

THE VAGUS NERVE SOCIETY IS OPEN TO SCIENTISTS AND CLINICIANS FROM ALL DISCIPLINES.

Accessibility Toolbar